Jeffrey Bluestone steps down from Parker Institute to lead biotech startup

Jeffrey Bluestone steps down from Parker Institute to lead biotech startup

Jeffrey Bluestone steps down as Parker Institute president to develop cell therapies for autoimmune diseases

By MATTHEW HERPER

COURTESY SONOMA

The startup, Sonoma Biotherapeutics, is trying to develop therapies that harness the immune system by treating not cancer but diseases of the immune system.

READ MORE